Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices

Transcatheter interventions enable safe and efficient treatment of various structural heart diseases. However, therapy does not finished with the end of the procedure. Device thrombosis is a possible serious complication. Therefore, careful patient management should include optimal antiplatelet or a...

Descripción completa

Detalles Bibliográficos
Autores principales: Olasinska-Wisniewska, Anna, Grygier, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568033/
https://www.ncbi.nlm.nih.gov/pubmed/31231662
http://dx.doi.org/10.3389/fcvm.2019.00075
_version_ 1783427198315659264
author Olasinska-Wisniewska, Anna
Grygier, Marek
author_facet Olasinska-Wisniewska, Anna
Grygier, Marek
author_sort Olasinska-Wisniewska, Anna
collection PubMed
description Transcatheter interventions enable safe and efficient treatment of various structural heart diseases. However, therapy does not finished with the end of the procedure. Device thrombosis is a possible serious complication. Therefore, careful patient management should include optimal antiplatelet or antithrombotic medication to enhance safe and complete endothelial coverage of the implanted device. In case of thrombus formation careful diagnostic evaluation and prompt treatment is crucial. This paper provides an update to current knowledge and understanding of prevention and management of device related thrombosis.
format Online
Article
Text
id pubmed-6568033
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65680332019-06-21 Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices Olasinska-Wisniewska, Anna Grygier, Marek Front Cardiovasc Med Cardiovascular Medicine Transcatheter interventions enable safe and efficient treatment of various structural heart diseases. However, therapy does not finished with the end of the procedure. Device thrombosis is a possible serious complication. Therefore, careful patient management should include optimal antiplatelet or antithrombotic medication to enhance safe and complete endothelial coverage of the implanted device. In case of thrombus formation careful diagnostic evaluation and prompt treatment is crucial. This paper provides an update to current knowledge and understanding of prevention and management of device related thrombosis. Frontiers Media S.A. 2019-06-07 /pmc/articles/PMC6568033/ /pubmed/31231662 http://dx.doi.org/10.3389/fcvm.2019.00075 Text en Copyright © 2019 Olasinska-Wisniewska and Grygier. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Olasinska-Wisniewska, Anna
Grygier, Marek
Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_full Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_fullStr Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_full_unstemmed Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_short Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
title_sort antithrombotic/antiplatelet treatment in transcatheter structural cardiac interventions—pfo/asd/laa occluder and interatrial shunt devices
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568033/
https://www.ncbi.nlm.nih.gov/pubmed/31231662
http://dx.doi.org/10.3389/fcvm.2019.00075
work_keys_str_mv AT olasinskawisniewskaanna antithromboticantiplatelettreatmentintranscatheterstructuralcardiacinterventionspfoasdlaaoccluderandinteratrialshuntdevices
AT grygiermarek antithromboticantiplatelettreatmentintranscatheterstructuralcardiacinterventionspfoasdlaaoccluderandinteratrialshuntdevices

Ejemplares similares